Get the Stockscreener App
6.11
5.12%
-0.33
After Hours:
6.11
Design Therapeutics Inc stock is traded at $6.11, with a volume of 84,157.
It is down -5.12% in the last 24 hours and up +17.50% over the past month.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
See More
Previous Close:
$6.44
Open:
$6.37
24h Volume:
84,157
Relative Volume:
0.59
Market Cap:
$347.95M
Revenue:
-
Net Income/Loss:
$-66.86M
P/E Ratio:
-5.0917
EPS:
-1.2
Net Cash Flow:
$-58.82M
1W Performance:
-2.24%
1M Performance:
+17.50%
6M Performance:
+33.12%
1Y Performance:
+13.57%
1-Day Range:
$6.07
$6.47
1-Week Range:
$5.98
$6.61
52-Week Range:
$2.60
$7.77
Design Therapeutics Inc Stock (DSGN) Company Profile
Name
Design Therapeutics Inc
Sector
Industry
Phone
858-293-4900
Address
6005 HIDDEN VALLEY ROAD, CARLSBAD
Compare DSGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DSGN
Design Therapeutics Inc
|
6.11 | 366.75M | 0 | -66.86M | -58.82M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Design Therapeutics Inc Stock (DSGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-14-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-15-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Aug-15-23 | Downgrade | SVB Securities | Outperform → Market Perform |
| Aug-15-23 | Downgrade | Wedbush | Outperform → Neutral |
| May-04-23 | Upgrade | Goldman | Sell → Neutral |
| Jun-10-22 | Initiated | Wedbush | Outperform |
| May-02-22 | Initiated | RBC Capital Mkts | Outperform |
| Jan-19-22 | Initiated | Goldman | Sell |
| Apr-20-21 | Initiated | Goldman | Neutral |
| Apr-20-21 | Initiated | Piper Sandler | Overweight |
| Apr-20-21 | Initiated | SVB Leerink | Outperform |
View All
Design Therapeutics Inc Stock (DSGN) Latest News
How to forecast Design Therapeutics Inc. trends using time seriesMarket Performance Report & Weekly Breakout Opportunity Watchlist - newser.com
Risk adjusted return profile for Design Therapeutics Inc. analyzedTrade Analysis Report & Short-Term Trading Opportunity Alerts - newser.com
Design Therapeutics Inc. stock outlook for YEARMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com
Analyzing Design Therapeutics Inc. with multi timeframe chartsEarnings Beat & Technical Entry and Exit Alerts - newser.com
Goldman Sachs Group Inc. Sells 31,113 Shares of Design Therapeutics, Inc. $DSGN - Defense World
Design Therapeutics Inc. recovery potential after sell offWeekly Earnings Recap & AI Powered Buy/Sell Recommendations - newser.com
Identifying reversal signals in Design Therapeutics Inc.2025 Market Outlook & Daily Technical Stock Forecast Reports - newser.com
Can CBRE Group Inc. recover in the next quarterMarket Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Top chart patterns to watch in Design Therapeutics Inc.Recession Risk & Verified Entry Point Detection - newser.com
Price Action: Is Design Therapeutics Inc stock heavily shortedJuly 2025 Summary & Verified Technical Trade Signals - خودرو بانک
Acadian Asset Management LLC Raises Stock Holdings in Design Therapeutics, Inc. $DSGN - MarketBeat
Is Wheeler Real Estate Investment Trust Inc. reversing from oversold territoryAnalyst Upgrade & High Accuracy Swing Trade Signals - newser.com
Market Leaders: Will XNET outperform during market ralliesJuly 2025 Momentum & Fast Gain Swing Trade Alerts - خودرو بانک
Is Design Therapeutics Inc stock influenced by commodity pricesJuly 2025 Recap & Fast Moving Market Watchlists - khodrobank.com
How to monitor Design Therapeutics Inc. with trend dashboardsM&A Rumor & Fast Entry Momentum Alerts - newser.com
Fitch Co. rally from current levelsBreakout Watch & Daily Stock Trend Watchlist - newser.com
How to use Fibonacci retracement on Design Therapeutics Inc.Portfolio Value Report & AI Powered Buy/Sell Recommendations - newser.com
National City Capital Trust IV Preferred Security stock daily chart insightsJuly 2025 Outlook & Daily Growth Stock Investment Tips - newser.com
Trend analysis for BAC.PRB this weekWall Street Watch & Capital Efficient Trade Techniques - newser.com
Fed Meeting: Is Design Therapeutics Inc. stock influenced by commodity pricesMarket Growth Report & Verified Stock Trade Ideas - khodrobank.com
What recovery options are there for Voyager Therapeutics Inc.Treasury Yields & Community Verified Trade Alerts - newser.com
Strategies to average down on ASGNGap Down & Low Risk Growth Stock Ideas - newser.com
Risk Report: Can Ryvyl Inc. be the next market leader2025 Market WrapUp & Weekly Top Gainers Trade List - خودرو بانک
Take Profit: Is NXP Semiconductors NV attractive at current valuationJuly 2025 EndofMonth & Long-Term Safe Return Strategies - khodrobank.com
Detecting support and resistance levels for Design Therapeutics Inc.Portfolio Return Report & Long-Term Safe Investment Ideas - newser.com
How to monitor AMC Entertainment Holdings Inc. with trend dashboardsMarket Growth Report & Community Verified Trade Alerts - newser.com
Market Catalysts: Is Mirion Technologies Inc being accumulated by smart moneyEarnings Recap Report & Low Volatility Stock Recommendations - khodrobank.com
How moving averages guide Design Therapeutics Inc. tradingNew Guidance & Safe Entry Point Identification - newser.com
Backblaze Inc. stock chart pattern explained2025 Institutional Moves & Growth Focused Entry Point Reports - newser.com
Can Design Therapeutics Inc. deliver alphaWeekly Trade Recap & Daily Technical Stock Forecast Reports - khodrobank.com
Aug Levels: What is Design Therapeutics Incs TAM Total Addressable Market2025 Investor Takeaways & Reliable Entry Point Alerts - خودرو بانک
Risk Off: Is ZYME part of any major indexAnalyst Upgrade & AI Forecast Swing Trade Picks - خودرو بانک
Risk Off: Can Design Therapeutics Inc expand its profit margins2025 Market WrapUp & Daily Growth Stock Tips - خودرو بانک
How to manage a losing position in Energy Vault Holdings Inc.Market Growth Report & Safe Capital Growth Trade Ideas - newser.com
Growth Value: Is Design Therapeutics Inc stock heavily shortedMarket Activity Recap & Fast Moving Stock Trade Plans - خودرو بانک
Should you hold or exit Design Therapeutics Inc. nowWeekly Stock Recap & Daily Profit Maximizing Tips - newser.com
Guidance Update: Is Design Therapeutics Inc stock influenced by commodity prices2025 Short Interest & Low Drawdown Trading Strategies - خودرو بانک
How to escape a deep drawdown in Kyverna Therapeutics Inc.Market Performance Summary & Consistent Growth Stock Picks - newser.com
Analyzing drawdowns of The Eastern Company with statistical toolsTake Profit & Precise Swing Trade Entry Alerts - newser.com
Design Therapeutics Inc. stock momentum explainedJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - Newser
Design Therapeutics Inc Stock (DSGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):